精神药物是否会导致发作?
Margaret Gopaul1,2, Hamada Altalib1,2
1Yale Comprehensive Epilepsy Center, Dept. of Neurology, Yale University School of Medicine New Haven, CT, USA.
Epilepsy & behavior reports
|June 17, 2024
概括
精神病的并发症在中很常见. 本综述详细介绍了抗抑郁药和抗精神病药物等精神药物使用的风险,以指导安全的患者护理并最大限度地减少发作.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 临床药理学 临床药理学
背景情况:
- 经常与精神疾病同时发生,使患者管理复杂化.
- 和精神疾病之间的关系是双向的,影响治疗策略.
- 心理药物通常是必要的,以管理患者的精神伴随性疾病.
研究的目的:
- 审查,精神病并发症和精神药物之间的复杂关系.
- 为临床决策提供有关在中使用精神药物的信息.
- 阐明与各种精神药物相关的发作风险.
主要方法:
- 经验证据和历史观点的文献综述.
- 分析与抗抑郁药,中枢神经系统刺激剂和抗精神病药物相关的风险.
- 综合当前对治疗时精神病并发症的理解.
主要成果:
- 三环抗抑郁药 (TCA) 携带的发作风险高于选择性血清素再吸收抑制剂 (SSRI),它们可能具有抗性质.
- 对于注意力缺陷/多动障碍 (ADHD) 的中枢神经系统 (CNS) 兴奋剂通常不会增加发作风险.
- 克洛扎是一种抗精神病药物,具有显著的发作风险,特别是在较高剂量和定位期间.
结论:
- 了解微妙的精神药物药物风险对于优化精神伴随性精神疾病患者的护理至关重要.
- 有信息的临床决策可以通过尽量减少阳发作来提高患者的安全性和治疗结果.
- 本综述为管理中精神病并发症的复杂性提供了实际见解.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
385
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
385
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
286
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
286
Antiepileptic Drugs: Sodium Channel Blockers
508
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
508
Antiepileptic Drugs: Potassium Channel Activators
169
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
169
Antiepileptic Drugs: Calcium Channel Blockers
369
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
369
Antiepileptic Drugs: Glutamate Antagonists
319
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
319


